Efficacy and Safety of Gemcitabine-Fluorouracil Combination Therapy in the Management of Advanced Pancreatic Cancer: A Meta-Analysis of Randomized Controlled Trials

BACKGROUND: Gemcitabine (GEM) is the standard first-line chemotherapy that provides limited clinical benefits for patients with locally advanced/metastatic pancreatic adenocarcinoma (LA/MPC). However, the fluorouracil derivatives (CAP and S-1) show promising efficacy in these patients. This study co...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qin, Yan, Han, Liu, Wenting, Zhen, Hongchao, Yang, Yifan, Cao, Bangwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4122434/
https://www.ncbi.nlm.nih.gov/pubmed/25093849
http://dx.doi.org/10.1371/journal.pone.0104346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4122434/
https://www.ncbi.nlm.nih.gov/pubmed/25093849
http://dx.doi.org/10.1371/journal.pone.0104346

Ejemplares similares